Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Abstract Text:

Silvio Danese,

Angiogenesis is the growth of new blood vessels. In the two major forms of inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, robust angiogenesis exists, and its blockade may have therapeutic potential, as shown in animal models of experimental intestinal inflammation. While abundant literature is available on the positive regulators of intestinal pathological angiogenesis, e.g. VEGF, b-FGF, IL-8, CD40 and CD40L, almost no data exist on negative regulators. Thrombospondin-1 is a negative regulator of angiogenesis, and it plays a new role in IBD-associated angiogenesis. In addition, recombinant thrombospondin-1 may inhibit pathological angiogenesis and may offer a new therapeutic approach to intestinal inflammation.

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Publishing Authors By Initials

S Danese,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Pathobiology : journal of immunopathology, molecul

VOLUME: 75

Page Numbers: 22-4

Journal Abbreviation:

ISSN: 1423-0291

DAY: 11

MONTH: 03

YEAR: 2008

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9007504

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.

AFFILIATION: Division of Gastroenterology, Istituto Clinico Humanitas-Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Italy. sdanese@hotmail.com

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pathobiology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight Related Publications

• Anti-adhesion molecule therapies in inflammatory bowel disease: Touch and go.
• Budesonide: teaching an old dog new tricks for inflammatory bowel disease treatment.
• Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis.
• Genetic opportunities for psychiatric epidemiology: on life stress and depression.
• Innate immunity in Crohn's disease: the reverse side of the medal.
• Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
• Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.
• Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.
• The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation.
• Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
• VEGF in inflammatory bowel disease: a master regulator of mucosal immune-driven angiogenesis.